View More Recent Stories

Jun 15, 2017 07:31AM Selecta Biosciences (SELB) Presents Completion of Follow on Breast Cancer Diagnostic Study
Jun 15, 2017 07:30AM Selecta Biosciences Reports Data from Ongoing Phase 2 Trial of Lead Candidate, SEL-212, in Development for Chronic Severe Gout
Jun 6, 2017 08:00AM Selecta Biosciences Announces Upcoming Clinical Presentations
May 31, 2017 08:00AM Selecta Biosciences to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 15, 2017 08:15AM Selecta Biosciences (SELB) Announces New Preclinical Gene Therapy Data at ASGCT
May 15, 2017 08:00AM Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 11, 2017 04:15PM Selecta Biosciences (SELB) Commences Dosing in Phase 1 Trial of Nicotine Vaccine for Smoking Cessation
May 11, 2017 04:05PM Selecta Biosciences Announces First Quarter 2017 Financial Results and Provides Corporate Update
May 11, 2017 04:01PM Selecta Biosciences Commences Dosing in Phase 1 Clinical Trial of Nicotine Vaccine for Smoking Cessation and Relapse Prevention
View More Recent Stories